The significantly higher mutational frequencies of TP53, MYC, FAT4, PBRM1, PREX2were observed in BC PD‐L1‐H cohort compared with that in PD‐L1‐L and PD‐L1‐negative cohort. The gene discussed is TP53; the disease is breast cancer.